147 related articles for article (PubMed ID: 16000217)
1. A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice.
Desai RI; Terry P; Katz JL
Pharmacol Biochem Behav; 2005 Aug; 81(4):843-8. PubMed ID: 16000217
[TBL] [Abstract][Full Text] [Related]
2. Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents.
Chausmer AL; Katz JL
Psychopharmacology (Berl); 2002 Jan; 159(2):145-53. PubMed ID: 11862342
[TBL] [Abstract][Full Text] [Related]
3. Behavioral effects of cocaine: interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys.
Katz JL; Kopajtic TA; Myers KA; Mitkus RJ; Chider M
J Pharmacol Exp Ther; 1999 Oct; 291(1):265-79. PubMed ID: 10490913
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434.
Platt DM; Rowlett JK; Spealman RD
J Pharmacol Exp Ther; 2000 Jun; 293(3):1017-26. PubMed ID: 10869406
[TBL] [Abstract][Full Text] [Related]
5. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
[TBL] [Abstract][Full Text] [Related]
6. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
[TBL] [Abstract][Full Text] [Related]
8. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393.
Ruskin DN; Rawji SS; Walters JR
J Pharmacol Exp Ther; 1998 Jul; 286(1):272-81. PubMed ID: 9655869
[TBL] [Abstract][Full Text] [Related]
9. DAD1- and DAD2-like agonist effects on motor activity of C57 mice: differences compared to rats.
Halberda JP; Middaugh LD; Gard BE; Jackson BP
Synapse; 1997 May; 26(1):81-92. PubMed ID: 9097408
[TBL] [Abstract][Full Text] [Related]
10. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
Tidey JW; Bergman J
J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
[TBL] [Abstract][Full Text] [Related]
11. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
Cauli O; Morelli M
Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the discriminative-stimulus effects of SKF 38393 with those of other dopamine receptor agonists.
Desai RI; Terry P; Katz JL
Behav Pharmacol; 2003 May; 14(3):223-8. PubMed ID: 12799524
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic administration of the D1 receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys.
Mutschler NH; Bergman J
Psychopharmacology (Berl); 2002 Apr; 160(4):362-70. PubMed ID: 11919663
[TBL] [Abstract][Full Text] [Related]
14. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists.
Berridge KC; Aldridge JW
Synapse; 2000 Sep; 37(3):194-204. PubMed ID: 10881041
[TBL] [Abstract][Full Text] [Related]
15. Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists.
Berridge KC; Aldridge JW
Synapse; 2000 Sep; 37(3):205-15. PubMed ID: 10881042
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D1 receptor changes due to caesarean section birth: effects of anesthesia, developmental time course, and functional consequences.
Boksa P; Zhang Y; Bestawros A
Exp Neurol; 2002 Jun; 175(2):388-97. PubMed ID: 12061868
[TBL] [Abstract][Full Text] [Related]
17. D(2), but not D(1) dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primates.
Meschler JP; Clarkson FA; Mathews PJ; Howlett AC; Madras BK
J Pharmacol Exp Ther; 2000 Mar; 292(3):952-9. PubMed ID: 10688609
[TBL] [Abstract][Full Text] [Related]
18. The relationship between reinforcing effects and in vitro effects of D1 agonists in monkeys.
Weed MR; Paul IA; Dwoskin LP; Moore SE; Woolverton WL
J Pharmacol Exp Ther; 1997 Oct; 283(1):29-38. PubMed ID: 9336305
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice.
Shannon HE; Peters SC
J Pharmacol Exp Ther; 1990 Nov; 255(2):549-53. PubMed ID: 2243341
[TBL] [Abstract][Full Text] [Related]
20. Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434.
Abrahams BS; Rutherford JD; Mallet PE; Beninger RJ
Eur J Pharmacol; 1998 Feb; 343(2-3):111-8. PubMed ID: 9570457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
